Benzinga··Vandana SinghBoston Scientific's Coronary Calcium Device Clears Pivotal Trial, Targeting $2B Market
Boston Scientific's SEISMIQ 4CE catheter achieves 93%+ safety and success rates in pivotal trial for severely calcified coronary disease, targeting multibillion-dollar market opportunity.
BSXclinical trialFDA clearance